Bird's eye view of natural products for the development of new anti-HIV agents: Understanding from a therapeutic viewpoint

IF 3.4 Q1 Health Professions Animal models and experimental medicine Pub Date : 2025-02-07 DOI:10.1002/ame2.12563
Md. Al Amin, Mohamed H. Nafady, Mehrukh Zehravi, Sherouk Hussein Sweilam, Kusuma Praveen Kumar, M. Akiful Haque, Aziz Unnisa, Laliteshwar Pratap Singh, Mohammed Sayeed, Mohammed Ali Alshehri, Irfan Ahmad, Talha Bin Emran, Md. Zia Uddin
{"title":"Bird's eye view of natural products for the development of new anti-HIV agents: Understanding from a therapeutic viewpoint","authors":"Md. Al Amin,&nbsp;Mohamed H. Nafady,&nbsp;Mehrukh Zehravi,&nbsp;Sherouk Hussein Sweilam,&nbsp;Kusuma Praveen Kumar,&nbsp;M. Akiful Haque,&nbsp;Aziz Unnisa,&nbsp;Laliteshwar Pratap Singh,&nbsp;Mohammed Sayeed,&nbsp;Mohammed Ali Alshehri,&nbsp;Irfan Ahmad,&nbsp;Talha Bin Emran,&nbsp;Md. Zia Uddin","doi":"10.1002/ame2.12563","DOIUrl":null,"url":null,"abstract":"<p>Acquired immune deficiency syndrome (AIDS) is the name used to describe several potentially life-threatening infections and disorders that happen when HIV has severely compromised the immune system. The primary effect of HIV is to decrease host immunity, exposing the host to external pathogens. The development of pharmaceutical drugs that directly cure the infection is crucial because of the current wide-ranging epidemic of HIV. Most therapeutic anti-HIV drugs are nucleosides. However, their high toxicity and potential for drug resistance restrict their use. Many of the most effective clinical drugs used to inhibit HIV, the activation of latent HIV, and AIDS have been obtained from natural sources. This review focuses on potential natural medicinal products for treating and managing HIV and AIDS. Notwithstanding, further clinical research studies are needed to understand the subject and its dynamics.</p>","PeriodicalId":93869,"journal":{"name":"Animal models and experimental medicine","volume":"8 3","pages":"441-457"},"PeriodicalIF":3.4000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ame2.12563","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Animal models and experimental medicine","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ame2.12563","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0

Abstract

Acquired immune deficiency syndrome (AIDS) is the name used to describe several potentially life-threatening infections and disorders that happen when HIV has severely compromised the immune system. The primary effect of HIV is to decrease host immunity, exposing the host to external pathogens. The development of pharmaceutical drugs that directly cure the infection is crucial because of the current wide-ranging epidemic of HIV. Most therapeutic anti-HIV drugs are nucleosides. However, their high toxicity and potential for drug resistance restrict their use. Many of the most effective clinical drugs used to inhibit HIV, the activation of latent HIV, and AIDS have been obtained from natural sources. This review focuses on potential natural medicinal products for treating and managing HIV and AIDS. Notwithstanding, further clinical research studies are needed to understand the subject and its dynamics.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
开发新型抗hiv药物的天然产物的鸟瞰图:从治疗角度的理解。
获得性免疫缺陷综合征(AIDS)是用来描述艾滋病毒严重损害免疫系统时发生的几种可能危及生命的感染和疾病的名称。HIV的主要作用是降低宿主免疫力,使宿主暴露于外部病原体。由于目前艾滋病毒的广泛流行,开发直接治愈这种感染的药物至关重要。大多数治疗性抗hiv药物都是核苷类。然而,它们的高毒性和潜在的耐药性限制了它们的使用。许多用于抑制HIV、激活潜伏HIV和艾滋病的最有效的临床药物都是从自然来源获得的。本文综述了治疗和管理艾滋病毒/艾滋病的潜在天然药物。尽管如此,需要进一步的临床研究来了解该主题及其动态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.50
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Cover Picture Issue Information Adhering to our original aspiration, forging ahead with determination—Editor in Chief's new year address Differences in cynomolgus macaque populations used for infectious disease research. Quantitative proteomics identifies clusterin as a novel biomarker for atherosclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1